These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

8070 related items for PubMed ID: 2254373

  • 1. In vitro and in vivo anticancer activity of mitozolomide and sparsomycin in human tumor xenografts, murine tumors and human bone marrow.
    Fiebig HH, Berger DP, Köpping K, Ottenheijm HC, Zylicz Z.
    J Cancer Res Clin Oncol; 1990; 116(6):550-6. PubMed ID: 2254373
    [Abstract] [Full Text] [Related]

  • 2. Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.
    Fiebig HH, Schmid JR, Bieser W, Henss H, Lohr GW.
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):937-48. PubMed ID: 3665999
    [Abstract] [Full Text] [Related]

  • 3. Antitumour activity and retinotoxicity of ethyldeshydroxy-sparsomycin in mice.
    Hofs HP, Wagener DJ, De Vos D, Ottenheijm HC, Winkens HJ, Bovee PH, De Grip WJ.
    Eur J Cancer; 1995 Jul; 31A(9):1526-30. PubMed ID: 7577083
    [Abstract] [Full Text] [Related]

  • 4. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
    Fodstad O, Aamdal S, Pihl A, Boyd MR.
    Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
    [Abstract] [Full Text] [Related]

  • 5. In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models.
    Zylicz Z, Wagener DJ, van Rennes H, van der Kleijn E, Lelieveld P, van den Broek LA, Ottenheijm HC.
    Invest New Drugs; 1988 Dec; 6(4):285-92. PubMed ID: 3229941
    [Abstract] [Full Text] [Related]

  • 6. The clonogenic assay with human tumor xenografts: evaluation, predictive value and application for drug screening.
    Berger DP, Henss H, Winterhalter BR, Fiebig HH.
    Ann Oncol; 1990 Sep; 1(5):333-41. PubMed ID: 2261375
    [Abstract] [Full Text] [Related]

  • 7. Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.
    Kjønniksen I, Breistøl K, Fodstad O.
    Cancer Res; 1992 Mar 01; 52(5):1347-51. PubMed ID: 1737396
    [Abstract] [Full Text] [Related]

  • 8. Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
    Pezzoni G, Grandi M, Biasoli G, Capolongo L, Ballinari D, Giuliani FC, Barbieri B, Pastori A, Pesenti E, Mongelli N.
    Br J Cancer; 1991 Dec 01; 64(6):1047-50. PubMed ID: 1764367
    [Abstract] [Full Text] [Related]

  • 9. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G.
    Cancer Chemother Pharmacol; 1996 Dec 01; 38(6):513-21. PubMed ID: 8823492
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide.
    Fairbairn LJ, Chinnasamy N, Lashford LS, Chinnasamy D, Rafferty JA.
    Cancer Gene Ther; 2000 Feb 01; 7(2):233-9. PubMed ID: 10770631
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS, Clement JJ.
    Cancer Res; 1989 Jun 01; 49(11):2935-40. PubMed ID: 2720652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor activity on murine tumors of a novel antitumor benzoylphenylurea derivative, HO-221.
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Fujimoto S, Tsukagoshi S, Taguchi T.
    Cancer Chemother Pharmacol; 1991 Jun 01; 28(5):351-6. PubMed ID: 1914078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE, Green D, Schein PS.
    Cancer Res; 1986 May 01; 46(5):2340-3. PubMed ID: 2938728
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 404.